FAILED
首站-论文投稿智能助手
典型文献
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
文献摘要:
Neuroendocrine neoplasms (NENs) are a highly heterogeneous class of tumors arising from neuroendocrine cells and peptidergic neurons. After failure of first-line treatment, patients have poor prognosis and limited treatment options. Immune checkpoint inhibitors (ICIs) may be a powerful means of increasing therapeutic efficacy for such patients, but ICIs alone have low response rates and short disease control durations in most NENs and may be effective for only a portion of the population. ICIs combined with other immunotherapies, targeted therapies, or cytotoxic drugs have achieved some efficacy in patients with NENs and are worthy of further exploration to assess their benefits to the population. In addition, accumulating experimental and clinical evidence supports that the interaction between neuroendocrine and immune systems is essential to maintain homeostasis, and assessment of this broad neuroendocrine-immune correlation is essential for NEN treatment. In this review, we summarize the immune microenvironment characteristics, advances in immunotherapy, predictive biomarkers of ICI efficacy for NENs, and the effects of common endocrine hormones on the immune system, highlighting possible new application areas for this promising treatment in neglected NENs.
文献关键词:
作者姓名:
Rilan Bai;Wenqian Li;Jiuwei Cui
作者机构:
Cancer Center,the First Hospital of Jilin University,Changchun 130021,China
引用格式:
[1]Rilan Bai;Wenqian Li;Jiuwei Cui-.Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives)[J].癌症生物学与医学(英文版),2022(12):1649-1661
A类:
peptidergic
B类:
Potential,new,applications,immunotherapy,neuroendocrine,neoplasms,immune,landscape,current,status,future,perspectives,Neuroendocrine,NENs,highly,heterogeneous,class,tumors,arising,from,cells,neurons,After,failure,first,line,treatment,patients,have,poor,prognosis,limited,options,Immune,checkpoint,inhibitors,ICIs,may,powerful,means,increasing,therapeutic,efficacy,such,but,alone,low,response,rates,short,disease,control,durations,most,effective,only,portion,population,combined,immunotherapies,targeted,cytotoxic,drugs,achieved,some,worthy,further,exploration,their,benefits,In,addition,accumulating,experimental,clinical,evidence,supports,that,interaction,between,systems,essential,maintain,homeostasis,assessment,this,broad,correlation,review,summarize,microenvironment,characteristics,advances,predictive,biomarkers,effects,common,hormones,highlighting,possible,areas,promising,neglected
AB值:
0.602205
相似文献
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。